These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26461071)

  • 41. [Analysis of the European Consensus on the treatment of opioid-induced constipation analgesic drugs.].
    Falbo PT; Cereda V; Manna G; Iannace A; Menghi A; Corona M; Lanzetta G
    Recenti Prog Med; 2019; 110(7):338-342. PubMed ID: 31379368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Naloxegol for the treatment of opioid-induced constipation.
    Tack J; Corsetti M
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
    Corsetti M; Tack J
    Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients.
    Ueberall MA; Müller-Lissner S; Buschmann-Kramm C; Bosse B
    J Int Med Res; 2011; 39(1):41-50. PubMed ID: 21672306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Bowel Function Index: a new validated scale for assessing opioid-induced constipation.
    Ducrotté P; Caussé C
    Curr Med Res Opin; 2012 Mar; 28(3):457-66. PubMed ID: 22236136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
    Jansen JP; Lorch D; Langan J; Lasko B; Hermanns K; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
    J Pain; 2011 Feb; 12(2):185-93. PubMed ID: 21292169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Naloxegol , a new drug for the treatment of opioid-induced constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2015 Feb; 16(3):399-406. PubMed ID: 25496063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.
    Gálvez R; Maire C; Tovar I; Vargas P
    A A Pract; 2018 Jul; 11(1):22-24. PubMed ID: 29634552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].
    van Dongen VC; Vanelderen PJ; Koopmans-Klein G; van Megen YJ; Van Zundert J; Huygen FJ
    Int J Clin Pract; 2014 Nov; 68(11):1364-75. PubMed ID: 24853258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden.
    Panchal SJ; Müller-Schwefe P; Wurzelmann JI
    Int J Clin Pract; 2007 Jul; 61(7):1181-7. PubMed ID: 17488292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chinese herbal medicine for opioid induced constipation in cancer patients: Protocol for a systematic review.
    Qi S; Lai H; Zhang Y; Dong Q; Zhu X
    Medicine (Baltimore); 2018 Sep; 97(39):e12594. PubMed ID: 30278572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study.
    Tokoro A; Imai H; Fumita S; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y
    Cancer Med; 2019 Aug; 8(10):4883-4891. PubMed ID: 31231974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation of a bowel function diary for assessing opioid-induced constipation.
    Camilleri M; Rothman M; Ho KF; Etropolski M
    Am J Gastroenterol; 2011 Mar; 106(3):497-506. PubMed ID: 21063394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What to Do and What Not to Do in the Management of Opioid-Induced Constipation: A Choosing Wisely Report.
    Alvaro D; Caraceni AT; Coluzzi F; Gianni W; Lugoboni F; Marinangeli F; Massazza G; Pinto C; Varrassi G
    Pain Ther; 2020 Dec; 9(2):657-667. PubMed ID: 32940898
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hot Topics in Primary Care: Management of Opioid-induced Constipation.
    Johnson DA; Argoff CE
    J Fam Pract; 2015 Dec; 64(12 Suppl):S4-9. PubMed ID: 26845012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence and clinical features of opioid-induced constipation in the general population: A French study of 15,000 individuals.
    Ducrotté P; Milce J; Soufflet C; Fabry C
    United European Gastroenterol J; 2017 Jun; 5(4):588-600. PubMed ID: 28588891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Survey of the Incidence of Constipation in Patients with Chronic Non-cancer Pain Using Opioid Analgesics in Japan.
    Sonohata M; Wada S; Koretaka Y; Morioka Y; Mishima H; Mawatari M
    Pain Ther; 2022 Sep; 11(3):845-859. PubMed ID: 35598289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Opioid-induced constipation.
    Gyawali B; Hayashi N; Tsukuura H; Honda K; Shimokata T; Ando Y
    Scand J Gastroenterol; 2015; 50(11):1331-8. PubMed ID: 26061717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The attractiveness of opposites: agonists and antagonists.
    O'Brien T
    J Pain Palliat Care Pharmacother; 2015 Mar; 29(1):67-9. PubMed ID: 25643224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.